Quest Diagnostics
DGX
#1081
Rank
NZ$35.65 B
Marketcap
NZ$318.89
Share price
0.86%
Change (1 day)
18.24%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$12.77 Billion

According to Quest Diagnostics 's latest financial reports the company has NZ$12.77 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Quest Diagnostics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$12.22 B20.48%
2023-12-31$NZ$10.14 B7.26%
2022-12-31$NZ$9.46 B-1.52%
2021-12-31$NZ$9.60 B0.59%
2020-12-31$NZ$9.55 B11.61%
2019-12-31$NZ$8.55 B7.41%
2018-12-31$NZ$7.96 B12.38%
2017-12-31$NZ$7.08 B3.67%
2016-12-31$NZ$6.83 B-2.14%
2015-12-31$NZ$6.98 B26.46%
2014-12-31$NZ$5.52 B14.31%
2013-12-31$NZ$4.83 B-4.99%
2012-12-31$NZ$5.08 B6.9%
2011-12-31$NZ$4.76 B-9.42%
2010-12-31$NZ$5.25 B-4.85%
2009-12-31$NZ$5.52 B-11.09%
2008-12-31$NZ$6.21 B43.14%
2007-12-31$NZ$4.33 B1.27%
2006-12-31$NZ$4.28 B6.01%
2005-12-31$NZ$4.04 B26.03%
2004-12-31$NZ$3.20 B-12.93%
2003-12-31$NZ$3.68 B8.99%
2002-12-31$NZ$3.37 B5.05%
2001-12-31$NZ$3.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
LabCorp
LH
NZ$15.08 B 18.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
NZ$8.88 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$1.45 B-88.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$75.13 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$6.31 B-50.52%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands